Krystal Biotech's VYJUVEK sees strong growth with $1B+ 2025 sales forecast. Check out why I rate KRYS as a Strong Buy and my ...

First patient dosed in the pediatric cohort of the Phase 1/2 trial of OPGx-LCA5; initial data on the cohort anticipated by Q3 2025New 12-month data on the first three adult OPGx-LCA5 patients to be pr ...

First patient dosed in the pediatric cohort of the Phase 1/2 trial of OPGx-LCA5; initial data on the cohort anticipated by Q3 2025New 12-month ...

Regeneron Pharmaceuticals' fourth quarter results beat my and Wall Street analysts' expectations. See why REGN stock is a top ...

A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a direct causal link with the drugs has not been established. That is the ...

You’re not alone if you struggle to swallow a pill that could rival a S$1 coin. Okay, we exaggerate but have you seen the size of some supplement tablets? Or you often end up with a wet face when ...

It picked up directly after the events of the season one finale cliffhanger, with the synopsis teasing more trouble in store for Owen and co. The official synopsis reads: ‘Season two of The ...

As Chinese AI startup DeepSeek draws attention for open-source AI models that it says are cheaper than the competition while providing similar or better performance, AI chip king Nvidia’s stock ...

Protheragen launches a full spectrum of ophthalmic drug preclinical R&D services to streamline the complex process of developing effective therapies for eye diseases. Protheragen, a reputable ...

But that’s not all, as we’ve got our first look at the game’s 2025 roadmap and an update on when we can expect the full 1.0 launch. Out today, Pact of the Flame is the fifth major content ...

Busà Photography / Getty Images Many people believe that being wealthy means having a nice house, a late-model car, and a summer cottage, but the kind of money possessed by the wealthiest 1% of ...